The antigen processing ability of both X-DCs and S-DCs was evaluated employing two distinct formulations of the MUC1 tumor glycoantigen: a soluble recombinant MUC1 glycoprotein (rMUC1) and tumor-derived MVs carrying MUC1 (MVsMUC1), isolated from the MUC1 transfected DG75 cell line (27). Here, MUC1 is linked to neoplasm.